株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医用画像の世界市場:製品タイプ、アプリケーション、地理別の成長率、動向および予測

Medical Imaging Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 660540
出版日 ページ情報 英文 115 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.21円で換算しております。
Back to Top
医用画像の世界市場:製品タイプ、アプリケーション、地理別の成長率、動向および予測 Medical Imaging Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年03月01日 ページ情報: 英文 115 Pages
概要

世界の医用画像市場は、2018年から2023年の予測期間中に、6.1%のCAGRで成長する見通しです。医用画像市場は、診断目的で使用される幅広い医療機器を対象とし、腫瘍学、整形外科、胃および婦人科など広範な分野で様々なアプリケーションがあります。高度な医療施設と医療費の増加により、北米はこの市場を支配し、その後欧州地域が支配的になると予想されています。

当レポートでは、世界の医用画像市場を調査し、全体的な市場動向、製品・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入者の脅威
    • 代替製品とサービスの脅威
    • 業界内での競争

第6章 成長要因、阻害要因、機会、課題の分析(DROC)

  • 成長要因
    • 慢性疾患の有病率の上昇
    • 医用画像における先端技術の採用増加
    • 高齢者人口の増加
  • 阻害要因
    • 高価な治療と設備
    • 診断画像の副作用
    • 先進国における成長の遅れ
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 製品タイプ別
    • X線装置
    • 蛍光透視法
    • MRI
    • 超音波
    • コンピュータ断層撮影
    • その他のイメージングモダリティ
  • アプリケーション別
    • 心臓病学
    • 腫瘍学
    • 神経学
    • 整形外科
    • 消化器病学
    • 婦人科
    • その他のアプリケーション
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • M&A分析
  • 合意、コラボレーション、パートナーシップ
  • 新製品の発売

第9章 主要企業

  • Carestream Health Inc.
  • Esoate SpA
  • 富士フィルム
  • GE Healthcare
  • 日立メディカルシステムズ
  • Hologic Corporation
  • Philips Healthcare
  • 島津メディカルシステムズ
  • Siemens Healthcare
  • キヤノンメディカルシステムズ など

第10章 市場の将来展望

目次
Product Code: 57005

Market Overview

The major factors augmenting the growth of the medical imaging market include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and rise in the geriatric population.

The burden of chronic diseases is on the rise globally, and medical imaging procedures play a crucial role in the accurate diagnosis of chronic diseases. The increase in the aging population and changes in societal behavior are contributing to a steady increase in these common and costly long-term health problems. Most of the deaths by chronic diseases are attributable to cardiovascular diseases, obesity, and diabetes. According to WHO, the global burden of chronic diseases is expected to reach 57% by 2020. The most affected would be the emerging markets, as the population growth is anticipated to be most significant in developing areas.

New models for therapy and diagnoses are being developed, which provide precise results, help in early detection of diseases, and help minimize the cost of treating these diseases. With the increasing disposable income, people are becoming capable enough to have access to imaging procedures for early detection of diseases.

Furthermore, the medical imaging field has advanced at a great pace, stimulated by advances in digital and communication technologies. New imaging techniques that reveal greater anatomical details are available in most of the diagnostic labs and hospitals. The aim is to improve access and precision, decrease cost, and make the impact of radiation less harmful. The trend is shifting from fixed to portable equipment. For example, until recently, size and electricity requirement have hindered the proper use of ultrasound. Today, smaller ultrasound equipment can provide color-flow Doppler imaging, relying on battery power solely.

Scope of the Report

As per the scope of the report, the medical imaging market covers a wide array of medical devices used for diagnostic purposes. It has a vast range of applications in a variety of oncological, orthopedic, gastro- and gynecological fields. With advanced healthcare facilities and growing healthcare expenditure, North America is expected to dominate this market, followed by the European region. The market is segmented by product type, application, and geography.

Key Market Trends

Oncology Segment under Application is expected to Account for Largest Market Share during the Forecast Period

Oncology deals with diagnosis and treatment of tumors and cancers, which is one the leading causes of morbidity and mortality. Among both sexes, lung, breast, and colorectal cancers are among the most common cancers in the world with lung cancer alone contributing to more than 13% of the total cases diagnosed.

According to WHO, cancer was responsible for 8.8 million deaths in 2015, including nearly 1 in 6 deaths globally. In addition, one-third of deaths are due to high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use (includes approximately 22% of cancer deaths), and alcohol use. Additionally, there are several minor side effects, such as nausea, headaches, dry mouth, diarrhea, allergic reaction, and others, as well as some major side effects, such as kidney disease, dementia, and others associated with its use, which can affect the adoption rate, and hence can be a restraining factor in the market.

Medical imaging plays a vital role in interventional oncology (with rising opportunities to diagnose and treat in a targeted and minimally or non-invasive manner) as well as in chemo and radiation therapy. Tools, such as CT, are the highly beneficial and preferred method of imaging for many conditions, including trauma patients. Comparatively, PET is mostly preferred as compared to SPECT, and there are hybrid medical devices also available such as PET/CT or PET/MRI.

North America accounted for the Largest Share in the Global Market

North America is found to hold a major share of the medical imaging market and is expected to show a similar trend over the forecast period, without significant fluctuations. The United States contributes to the major share in the medical imaging market, which can be attributed to the increasing technological advances, higher affordability rates from the population, and the number of diagnostic procedures increasing on a yearly basis. According to OECD, till 2007, the number of MRI units being available per one million of the population was 25.9. The volume rose to approximately 39 by 2015, reported as of 2017, including 20.3 in ambulatory services and 18.7 in hospitals. MRI diagnostic is a growing field, both in terms of the number of the installed scanner and in the number of scans being performed. Based on the data by OECD, the United States is one of the leaders, second only to Japan, both in terms of availability and utilization.

Hence, with the presence of well-established healthcare facilities, increasing demand for advanced healthcare systems among the aging population, and increasing prevalence of chronic diseases, the market is expected to grow in the forecast period.

Competitive Landscape

The market studied is consolidated owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence few major market players hold the maximum market share.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Prevalence of Chronic Diseases
    • 4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
    • 4.2.3 Increase in the Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures and Equipment
    • 4.3.2 Side Effects of Diagnostic Imaging
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 X-Ray Equipment
      • 5.1.1.1 Stationary
      • 5.1.1.2 Portable
    • 5.1.2 Fluoroscopy
      • 5.1.2.1 Fixed Fluoroscope
      • 5.1.2.2 Mobile Fluoroscope
    • 5.1.3 MRI
      • 5.1.3.1 Closed Systems
      • 5.1.3.2 Open Systems
    • 5.1.4 Ultrasound
    • 5.1.5 Computed Tomography
    • 5.1.6 Other Imaging Modalities
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Oncology
    • 5.2.3 Neurology
    • 5.2.4 Orthopedics
    • 5.2.5 Gastroenterology
    • 5.2.6 Gynecology
    • 5.2.7 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 Carestream Health Inc.
    • 6.1.3 Esaote SpA
    • 6.1.4 FUJIFILM Holdings Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 Hitachi Medical Systems
    • 6.1.7 Hologic Corporation
    • 6.1.8 Koninklijke Philips N.V.,
    • 6.1.9 Shimadzu Medical
    • 6.1.10 Siemens Healthineers

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top